NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.84% | -24.84% | -16.18% | -0.35% | 25.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.84% | -24.84% | -16.18% | -0.35% | 25.64% |
| Cost of Revenue | -16.71% | -16.71% | -44.47% | -11.00% | 69.82% |
| Gross Profit | -50.89% | -50.89% | 173.93% | 17.47% | -31.48% |
| SG&A Expenses | 283.57% | 283.57% | 4,635.65% | -3.74% | -24.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.83% | 76.83% | 83.62% | -8.62% | 22.30% |
| Operating Income | -1,026.70% | -1,026.70% | -567.83% | 110.00% | 1.98% |
| Income Before Tax | 279.99% | 279.99% | -283.59% | -128.08% | -31.46% |
| Income Tax Expenses | -- | -- | -481.48% | -- | -- |
| Earnings from Continuing Operations | 279.99% | 279.99% | -114.76% | -128.08% | -2.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 406.82% | 406.82% | -19.68% | 294.44% | -112.43% |
| Net Income | 282.80% | 282.80% | -132.24% | -119.41% | -28.85% |
| EBIT | -1,026.70% | -1,026.70% | -567.83% | 110.00% | 1.98% |
| EBITDA | -1,074.76% | -1,074.76% | -521.89% | 112.58% | -0.36% |
| EPS Basic | 106.72% | 106.72% | -125.34% | -- | -- |
| Normalized Basic EPS | -- | -- | -318.06% | -- | -- |
| EPS Diluted | 101.86% | 101.86% | -125.40% | -- | -- |
| Normalized Diluted EPS | -- | -- | -318.06% | -- | -- |
| Average Basic Shares Outstanding | -- | -- | 27.19% | -- | -- |
| Average Diluted Shares Outstanding | 9,767.33% | 9,767.33% | 27.19% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |